FEPUX | TIOIX | FEPUX / TIOIX | |
Total Expense Ratio | 0.52 | 0.60 | 87% |
Annual Report Gross Expense Ratio | 0.52 | 0.60 | 87% |
Fund Existence | 4 years | 12 years | - |
Gain YTD | 0.056 | -1.295 | -4% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 120B | 2.17B | 5,522% |
Annual Yield % from dividends | 1.45 | 1.49 | 98% |
Returns for 1 year | -3.60 | -0.51 | 703% |
Returns for 3 years | 2.80 | -1.36 | -207% |
Returns for 5 years | N/A | 26.44 | - |
Returns for 10 years | N/A | 38.13 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BEOIX | 8.09 | 0.11 | +1.38% |
Barrow Hanley Concentrated EM ESG Opps I | |||
FIJZX | 42.83 | 0.37 | +0.87% |
Fidelity Advisor Consumer Discret Z | |||
IVGSX | 20.60 | 0.03 | +0.15% |
VY® Invesco Growth and Income S | |||
JFNAX | 63.10 | 0.02 | +0.03% |
Janus Henderson Global Life Sciences A | |||
ITGIX | 84.30 | -0.28 | -0.33% |
VY® T. Rowe Price Growth Equity I |